Donley Matthew's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 97,256 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 27 Feb 2026 | 97,256 | 97,256 | - | - | Employee Stock Option (right to buy) | ||
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 27 Feb 2026 | 58,160 | 721,060 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 27 Feb 2026 | 40,761 | 680,299 (0%) | 0% | 14.2 | 579,214 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 20 Feb 2026 | 32,901 | 662,900 (0%) | 0% | 14.4 | 473,774 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 02 Jan 2026 | 54,166 | 734,631 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 02 Jan 2026 | 42,787 | 695,801 (0%) | 0% | 16.0 | 682,453 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 135,567 | 805,358 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 126,416 | 126,416 | - | - | Employee Stock Option (right to buy) | ||
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 82,781 | 669,791 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 65,902 | 739,456 (0%) | 0% | 8 | 527,216 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 58,991 | 680,465 (0%) | 0% | 7.9 | 467,209 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | EVP, Ops & Strategy | 06 Mar 2024 | 40,665 | 584,072 (0%) | 0% | 5.5 | 224,064 | Common Stock | |
| Aurinia Pharma Inc | Donley Matthew | EVP, Ops & Strategy | 20 Feb 2024 | 216,666 | 624,737 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | EVP, Ops & Strategy | 02 Mar 2023 | 271,134 | 403,141 (0%) | 0% | - | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | Ex VP, Internal Operations | 21 Nov 2022 | 10,000 | 27,927 (0%) | 0% | 4.7 | 46,600 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | Ex VP, Internl Operations | 02 Mar 2022 | 178,063 | 178,063 | - | - | Stock Option (right to buy) | ||
| Aurinia Pharma Inc | Matthew Donley | Ex VP, Internl Operations | 02 Mar 2022 | 104,080 | 104,080 | - | - | Restricted Stock Unit | ||
| Aurinia Pharma Inc | Matthew Donley | Ex VP, Internl Operations | 02 Mar 2022 | 8,500 | 19,276 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Matthew Donley | Ex VP, Internl Operations | 02 Mar 2022 | 3,052 | 16,224 (0%) | 0% | 12.0 | 36,655 | Common Stock |